Research And Grants

CONNECT Consortium (TarGeT 2027) - $6,445 USD / $10,000 AUD
Dr. Nick Gottardo
Grant Amount
$6,445.00
Date
December 2024
Research Type
Clinical
Cancer Type
DIPG/DMG
TarGeT 2027
- Precision Medicine: TarGeT aligns with emerging data suggesting that personalised treatment significantly enhances outcomes for high-risk brain cancers.
- Local Participation: The trial will involve five CONNECT member hospitals across Australasia, enabling substantial enrolment from local young patients.
- Global Collaboration: ANZCHOG’s coordination with CONNECT will allow Australian and New Zealand patients to access globally recognised, cutting-edge therapies developed through extensive international collaboration.